Index of artpub/2025/321753/

Jiménez-Vicente, Carlos
Allo-HCT refined ELN 2022 risk classification : validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC)
2025
https://ddd.uab.cat/record/321753
[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[TXT]321753.dupdirs2025-11-23 05:08 0  
[TXT]321753.dupfiles2025-11-23 05:08 0  
[TXT]321753.txt2025-11-23 05:08 0  
[ ]3=20252025-11-22 15:59 5  
[ ]1=Jimenez-Vicente,_Carlos2025-11-22 15:59 25  
[ ]321753.du2025-11-23 05:08 29  
[TXT]321753.errors2025-11-23 05:08 29  
[ ]4=3217532025-11-22 15:59 34  
[TXT]321753.md52025-11-23 05:08 45  
[TXT]321753.sha12025-11-23 05:08 53  
[TXT]321753.sha2562025-11-23 05:08 77  
[ ]2=Allo-HCT_refined_ELN_2022_risk_classification...2025-11-22 15:59 237  
[TXT]321753.stats2025-11-23 05:08 268  
[TXT]321753.dirinfo2025-11-23 05:08 318  
[IMG]321753.ico2025-11-23 05:08 12K 
[IMG]321753.gif2025-11-23 05:08 36K 
[TXT]321753.info2025-11-23 05:08 55K 
[ ]321753.pdf2025-11-23 05:08 1.4M